
Ankeet Bhatt, MD, MBA, ScM, explains how prediction markets could threaten clinical trial integrity by undermining participant retention and trust.
Panelists discuss the high rates of missed chronic kidney disease (CKD) diagnoses despite testing and the consequences of diagnosing CKD in patients with type 2 diabetes without administering treatment, including insights on how frequently this occurs among cardiologists and primary care providers.






